Keywords: AktheRx Pharma, GlaxoSmirhKline, Solabegron, OAB, IBS, Asset purchase

AltheRx buys GSK mid-stage cast-off OAB/IBS drug solabegron

Article | 29 March 2011

Print This

AltheRx Pharmaceuticals, a privately-held US clinical development company set up just a year ago, says it has purchased all assets ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in